Hookipa Pharma develops prophylactic and therapeutic vaccines for the prevention and treatment of multiple infectious diseases and cancer. The company provides a proprietary technology platform, VaxwaveTM, that introduces an approach to vaccination by providing long lasting and potent stimulation of both cellular and humoral immunity.
Net income (Q2, 2020)
EBIT (Q2, 2020)
Market capitalization (26-Feb-2021)
Closing stock price (26-Feb-2021)
|Company Name||Date||Deal Size|
|Hookipa Biotech GmbH|
Hookipa Pharma has 397 Twitter Followers. The number of followers has increased 3.9% month over month and increased 6.5% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Hookipa Pharma founded?
Hookipa Pharma was founded in 2011.
How many employees does Hookipa Pharma have?
Hookipa Pharma has 60 employees.
What is Hookipa Pharma revenue?
Latest Hookipa Pharma annual revenue is $11.9 m.
What is Hookipa Pharma revenue per employee?
Latest Hookipa Pharma revenue per employee is $199 k.
Who are Hookipa Pharma competitors?
Competitors of Hookipa Pharma include ExeVir Bio, Psicologia Viva and Brightline.
Where is Hookipa Pharma headquarters?
Hookipa Pharma headquarters is located at Helmut-Qualtinger-Gasse 2, Wien.
Where are Hookipa Pharma offices?
Hookipa Pharma has offices in Wien and New York.
How many offices does Hookipa Pharma have?
Hookipa Pharma has 2 offices.
Receive alerts for 300+ data fields across thousands of companies